Table 2.
Imaging and blood-based biomarker results.
| Hemisphere of DWI lesion | |
|---|---|
| Right | 46 (51.7) |
| Left | 32 (36.0) |
| Bilateral | 11 (12.4) |
| DWI lesion volume on acute MRI, ml | 5.7 (12.8) |
| PI deficit volume on acute MRI, ml | 45.1 (78.0) |
| DWI-PI mismatch on acute MRI, ml | 26.4 (58.5) |
| TYPE OF INFARCTION | |
| Territorial | 76 (85.4) |
| Lacunar infarction | 12 (13.5) |
| Borderzone infarction | 1 (1.1) |
| REGIONS AFFECTED | |
| Any Cortex | 54 (60.7) |
| Caudate | 3 (3.3) |
| Lenticulate | 4 (4.4) |
| Capsula interna | 8 (8.8) |
| Insula | 11 (12.1) |
| ASPECT M1 | 6 (6.6) |
| ASPECT M2 | 17 (18.7) |
| ASPECT M3 | 14 (15.4) |
| ASPECT M4 | 15 (16.5) |
| ASPECT M5 | 34 (37.4) |
| ASPECT M6 | 21 (23.1) |
| FLAIR lesion volume on Follow Up, ml [33] | 10.0 (14.9) |
| HLA-DR, EPITOPES/CELL, MEDIAN (IQR) | |
| At inclusion [3] | 18,387 (14,434–25,788) |
| Lowest [1] | 16,505 (11,386–21,285) |
| IL-6, PG/ML, MEDIAN (IQR) | |
| At inclusion [3] | 2.8 (2.0–5.2) |
| Highest [1] | 5.2 (2.7–11.0) |
| IL-8, PG/ML, MEDIAN (IQR) | |
| At inclusion [3] | 5.0 (5.0–5.0) |
| Highest [1] | 5.0 (5.0–5.2) |
| IL-10, PG/ML, MEDIAN (IQR) | |
| At inclusion [3] | 5.0 (5.0–5.0) |
| Highest [1] | 5.0 (5.0–5.0) |
| LBP, μG/ML, MEDIAN (IQR) | |
| At inclusion [3] | 7.23 (5.48–9.34) |
| Highest [1] | 8.90 (6.68–11.65) |
| MPproANP, PG/ML, MEDIAN (IQR) | |
| At inclusion [29] | 111.4 (65.5–180.9) |
| Highest [23] | 122.5 (79.1–195.8) |
| MPproADM, PG/ML, MEDIAN (IQR) | |
| At inclusion [29] | 0.703 (0.593–0.868) |
| Highest [22] | 0.751 (0.613–0.917) |
| CTproET, PG/ML, MEDIAN (IQR) | |
| At inclusion [30] | 61.4 (50.7–75.9) |
| Highest [22] | 64.4 (54.6–83.1) |
| CPus, PG/ML, MEDIAN (IQR) | |
| At inclusion [29] | 8.84 (5.27–14.22) |
| Highest [22] | 10.19 (5.60–17.40) |
| PCT us, PG/ML, MEDIAN (IQR) | |
| At inclusion [30] | 0.031 (0.024–0.041) |
| Highest [23] | 0.039 (0.028–0.050) |
Values given are n (%) if not explicitly stated otherwise, missing cases reported if >5 as [n]. HLA-DR, Human leukocyte antigen expression on monocytes; IL-6, IL-8, IL-10, three interleukins; LBP, lipopolysaccharide-binding protein; MRproANP, mid-regional pro atrial natriuretic peptide; MRproADM, mid-regional pro adrenomedullin; CTproET, C-terminal pro endothelin; CPus, ultrasensitive copeptin; PCTus, ultrasensitive procalcitonin.